A Novel Pathogenic Sense Variant in Exon 7 of the HK1 Gene in a Patient with Hexokinase Deficiency and Gilbert Syndrome
Genes · 07.12.2024 · 15 (12) · 1576
DOI: 10.3390/genes15121576 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, online erschienen am 07.12.2024. Verfasst von Magdalena Bartnik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics Hemato-Oncology and Paediatric Gastroenterology, Pomeranian Medical University, 70-204 Szczecin, Poland. Hauptthemen laut MEDLINE: Hexokinase, Gilbert Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hexokinase (HK) deficiency is a rare autosomal recessively inherited disease manifested by chronic nonspherocytic hemolytic anemia. Most patients present with a mild to severe course of the disease (fetal hydrocephalus, neonatal hyperbilirubinemia, severe anemia). We reviewed 37 cases of patients with hexokinase deficiency described so far, focusing on the severity of the disease, clinical presentation, treatment applied, and genetic test results.
Methods
We present a 10-year-old girl who initially presented with symptoms of weakness, excessive fatigue, and yellowing of the skin and sclerae. Genetic testing detected the (TA)7 variant in both alleles of the UGT1A1 gene and diagnosed Gilbert’s disease. In the follow-up, red cell hemolysis was observed. The diagnosis was extended, and tests for red cell enzymopathy were performed and a reduced level of hexokinase—0.65 IU/gHb (normal 0.78–1.57) was found. Next-generation sequencing revealed a new sense-change variant in exon 7 in the hexokinase gene not previously reported in databases.
Results
Up to this date, only around 37 cases of hexokinase deficiency associated with hereditary nonspherocytic hemolytic anemia have been documented around the world. Diagnosing hexokinase deficiency involves clinical evaluation, laboratory testing, and genetic analysis. Management focuses on treating symptoms and preventing complications; there is no cure for the underlying enzyme deficiency. In patients with severe anemia, the treatment is multiple blood transfusions followed by iron chelation therapy.
Conclusions
Understanding and diagnosing hexokinase deficiency is critical for providing appropriate care and improving the quality of life for affected individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics Hemato-Oncology and Paediatric Gastroenterology, Pomeranian Medical University, 70-204 Szczecin, Poland.
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 01-447 Warsaw, Poland.
ORCID-Profile: Weronika Pawlik
Zitieren
APA
Bartnik, M., Pawlik, W., Burzyńska, B., Wasilewski, K., Kamieńska, E., & Urasiński, T. (2024). A Novel Pathogenic Sense Variant in Exon 7 of the HK1 Gene in a Patient with Hexokinase Deficiency and Gilbert Syndrome. Genes, 15(12), 1576. https://doi.org/10.3390/genes15121576
Vancouver
Bartnik M, Pawlik W, Burzyńska B, Wasilewski K, Kamieńska E, Urasiński T. A Novel Pathogenic Sense Variant in Exon 7 of the HK1 Gene in a Patient with Hexokinase Deficiency and Gilbert Syndrome. Genes. 2024;15(12):1576. doi:10.3390/genes15121576
BibTeX
@article{Bartnik2024,
author = {Bartnik, Magdalena and Pawlik, Weronika and Burzyńska, Beata and Wasilewski, Konrad and Kamieńska, Elżbieta and Urasiński, Tomasz},
title = {A Novel Pathogenic Sense Variant in Exon 7 of the HK1 Gene in a Patient with Hexokinase Deficiency and Gilbert Syndrome},
journal = {Genes},
year = {2024},
volume = {15},
number = {12},
pages = {1576},
doi = {10.3390/genes15121576}
}
EUVIMED